Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region
We report for the first time a patient with malaria due to Plasmodium vivax who showed R2 resistance to chloroquine and R3 resistance to mefloquine in the Brazilian Amazon region based on WHO clinical criteria for diagnosis of malaria resistance. Failure was observed with unsupervised oral chloroquine, chloroquine under rigorous supervision and mefloquine in the same scheme. Finally, the patient was cured with oral artesunate.
Saved in:
Main Authors: | Alecrim,Maria das Graças C., Alecrim,Wilson, Macêdo,Vanize |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
1999
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86821999000100013 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Chloroquine and mefloquine resistance profiles are not related to the circumsporozoite protein (CSP) VK210 subtypes in field isolates of Plasmodium vivax from Manaus, Brazilian Amazon
by: Pratt-Riccio,Lilian Rose, et al.
Published: (2019) -
Genetic diversity of chloroquine-resistant Plasmodium vivax parasites from the western Brazilian Amazon
by: Lizcano,Omaira Vera, et al.
Published: (2014) -
Slow clearance of Plasmodium vivax with chloroquine amongst children younger than six months of age in the Brazilian Amazon
by: Siqueira,André M, et al.
Published: (2014) -
Assessment of chloroquine single dose treatment of malaria due to Plasmodium vivax in Brazilian Amazon
by: Pinto,Ana Yecê das Neves, et al.
Published: (2003) -
Emerging Plasmodium vivax resistance to chloroquine in South America: an overview
by: Gonçalves,Lígia Antunes, et al.
Published: (2014)